Results 211 to 220 of about 3,496 (222)
Some of the next articles are maybe not open access.

Vulvar Lichen Sclerosus: Diagnosis and Management

The Journal for Nurse Practitioners, 2014
Abstract Vulvar lichen sclerosus (VLS) is a chronic, inflammatory skin condition of the vulva that most commonly affects postmenopausal women. Although there is currently no cure, modern treatments can effectively manage VLS once diagnosed. Unfortunately, vulvar conditions are routinely underdiagnosed and undertreated.
Nicholas Wedel, Laura Johnson
openaire   +2 more sources

Vulvar squamous cell carcinoma and lichen sclerosus

Australasian Journal of Dermatology, 1997
There are two clinicopathological types of vulvar squamous cell carcinoma, human papillomavirus (HPV)-positive and HPV-negative, which can be distinguished to some degree on routine histology. Human papillomavirus-positive carcinomas account for one-quarter to one-third of cases, occur in women on average 20 years younger than in HPV-negative, and are ...
Katrina Vanin, James Scurry
openaire   +3 more sources

Topical tacrolimus forĀ recalcitrant vulvar lichen sclerosus

European Journal of Dermatology, 2009
Auteur(s) : Eleni Sotiriou, Zoi Apalla, Aikaterini Patsatsi, Despina Panagiotidou First dermatologic department, Medical school, Aristotle university Thessaloniki, 8, Papakyriazi str, 54645 Thessaloniki, Greece Vulvar lichen sclerosus (VLS) is a chronic inflammatory skin disorder of uncertain origin predominantly affecting postmenopausal women.
Eleni Sotiriou   +3 more
openaire   +3 more sources

Familial Vulvar Dystrophy of Lichen Sclerosus Type

Archives of Dermatology, 1982
Lichen sclerosus et atrophicus (LS&A) of the vulva and perianal skin is an atrophic condition that con occur alone or in association with additional lesions situated elsewhere on the skin surface. The cases of three sisters with LS&A of the vulva are reported herein; in one a squamous cell carcinoma developed in a hyperplastic area of mixed dystrophy ...
Herbert F. Haberman   +2 more
openaire   +3 more sources

Tacrolimus ointment for the treatment of vulvar lichen sclerosus

Journal of the American Academy of Dermatology, 2003
The treatment of vulvar lichen sclerosus is generally considered difficult. Ultrapotent corticosteroids represent the most effective topical treatment, but carry the risk of side effects such as skin atrophy. We describe a 71-year-old woman with long-standing vulvar lichen sclerosus refractory to conventional treatment.
Petra Maria Becker-Wegerich   +4 more
openaire   +2 more sources

Vulvar Lichen Sclerosus

Journal of Obstetrics and Gynaecology Canada, 2010
Sirine El-Khatib, Michael Shier
openaire   +3 more sources

Treatment of Refractory Vulvar Lichen Sclerosus With Methotrexate

Journal of Lower Genital Tract Disease
We report the successful treatment of severe vulvar lichen sclerosus refractory to topical corticosteroids in 3 adult female patients using low-dose oral methotrexate. All cases reported symptomatic and clinical improvement within 12 weeks.
Afsoon, Ghafari-Saravi, Erin, Foster
openaire   +2 more sources

[Our experience in treating vulvar lichen sclerosus].

Minerva ginecologica, 1997
The authors looking for a better treatment of vulvar lichen sclerosus, treated 10 patients by topical application of clobetasol propionate (twice a day for 45 days and once a day for additional 45 days). Before and after therapy changes of subjective symptoms were studied with Vaona algometer as well as the histological modifications found in the ...
CATTANI, Paolo   +4 more
openaire   +2 more sources

Eosinophilic spongiosis in vulvar lichen sclerosus

The Journal of Dermatology, 2012
Masanobu Kumakiri   +2 more
openaire   +2 more sources

Vulvar lichen sclerosus

2017
Jill M. Krapf, Andrew T. Goldstein
openaire   +1 more source

Home - About - Disclaimer - Privacy